COVID-19 Outcomes and Vaccination in Ofatumumab-treated RMS Patients: ALITHIOS Trial and Post-marketing Setting

Habek, M.; Cross, A.; Delgado, S.; Davydovskaya, M.; Ward, B.; Cree, B.; Totolyan, N.; Mancione, L.; Sullivan, R.; Zielman, R.; Hu, X.; Das Gupta, A.; Montalban, X.; Winthrop, K.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

COVID-19 Outcomes and Vaccination in Ofatumumab-treated RMS Patients: ALITHIOS Trial and Post-marketing Setting

Habek, M.; Cross, A.; Delgado, S.; Davydovskaya, M.; Ward, B.; Cree, B.; Totolyan, N.; Mancione, L.; Sullivan, R.; Zielman, R.; Hu, X.; Das Gupta, A.; Montalban, X.; Winthrop, K..

EUROPEAN JOURNAL OF NEUROLOGY ; 29:291-292, 2022.

Article in English | Web of Science | ID: covidwho-1965375

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Randomized controlled trials Topics: Vaccines Language: English Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Randomized controlled trials Topics: Vaccines Language: English Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2022 Document Type: Article